As shown in Table 1, generally and significantly higher expression levels of POLE2 were observed in tumor tissues compared with normal tissues (P < 0.001), indicating the potential involvement of POLE2 in the development and progression of ESCC. The gene discussed is POLE2; the disease is neoplasm.